Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3ocg | OCG | Mitogen-activated protein kinase 14 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 3ocg | OCG | Mitogen-activated protein kinase 14 | / | 1.000 | |
| 4kin | 1M8 | Mitogen-activated protein kinase 14 | / | 0.595 | |
| 2rg6 | 287 | Mitogen-activated protein kinase 14 | / | 0.584 | |
| 3fkl | FKL | Mitogen-activated protein kinase 14 | / | 0.578 | |
| 4aa5 | NQB | Mitogen-activated protein kinase 14 | / | 0.574 | |
| 4kiq | 1RA | Mitogen-activated protein kinase 14 | / | 0.574 | |
| 3mpt | 1GK | Mitogen-activated protein kinase 14 | / | 0.573 | |
| 3iph | G11 | Mitogen-activated protein kinase 14 | / | 0.570 | |
| 4kip | 1R9 | Mitogen-activated protein kinase 14 | / | 0.569 | |
| 3nww | 3NW | Mitogen-activated protein kinase 14 | / | 0.568 | |
| 2rg5 | 279 | Mitogen-activated protein kinase 14 | / | 0.565 | |
| 4aac | AAV | Mitogen-activated protein kinase 14 | / | 0.563 | |
| 3fsk | RO6 | Mitogen-activated protein kinase 14 | / | 0.545 | |
| 3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.543 | |
| 2bal | PQA | Mitogen-activated protein kinase 14 | / | 0.536 | |
| 3dt1 | P40 | Mitogen-activated protein kinase 14 | / | 0.529 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.528 | |
| 4aa4 | QC0 | Mitogen-activated protein kinase 14 | / | 0.527 | |
| 3mvm | 39P | Mitogen-activated protein kinase 14 | / | 0.524 | |
| 3hl7 | I47 | Mitogen-activated protein kinase 14 | / | 0.523 | |
| 3l8x | N4D | Mitogen-activated protein kinase 14 | / | 0.522 | |
| 3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.518 | |
| 3fi4 | FI4 | Mitogen-activated protein kinase 14 | / | 0.517 | |
| 3flz | FLZ | Mitogen-activated protein kinase 14 | / | 0.517 | |
| 3fmk | FMK | Mitogen-activated protein kinase 14 | / | 0.513 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.510 | |
| 3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.506 | |
| 3mvl | 38P | Mitogen-activated protein kinase 14 | / | 0.506 | |
| 2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.505 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.502 | |
| 3fmh | 533 | Mitogen-activated protein kinase 14 | / | 0.500 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.500 | |
| 3el8 | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.498 | |
| 3gfe | P37 | Mitogen-activated protein kinase 14 | / | 0.495 | |
| 2zb0 | GK3 | Mitogen-activated protein kinase 14 | / | 0.494 | |
| 4eh6 | 0ON | Mitogen-activated protein kinase 14 | / | 0.493 | |
| 1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.491 | |
| 3w2r | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.491 | |
| 3gu8 | 3GU | Death-associated protein kinase 1 | 2.7.11.1 | 0.490 | |
| 1zz2 | B11 | Mitogen-activated protein kinase 14 | / | 0.488 | |
| 2og8 | 1N8 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.488 | |
| 3flw | FLW | Mitogen-activated protein kinase 14 | / | 0.486 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.486 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.485 | |
| 3uib | SB2 | Putative mitogen-activated protein kinase | / | 0.485 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.485 | |
| 3fly | FLY | Mitogen-activated protein kinase 14 | / | 0.483 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.483 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.482 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.481 | |
| 2ghl | LIB | Mitogen-activated protein kinase 14 | / | 0.481 | |
| 1ywr | LI9 | Mitogen-activated protein kinase 14 | / | 0.480 | |
| 3u8w | 09J | Mitogen-activated protein kinase 14 | / | 0.480 | |
| 4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.480 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.479 | |
| 4loo | SB4 | Mitogen-activated protein kinase 14 | / | 0.479 | |
| 4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.479 | |
| 2wou | ZZF | TGF-beta receptor type-1 | 2.7.11.30 | 0.478 | |
| 3ac2 | KSE | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.478 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.478 | |
| 3hvc | GG5 | Mitogen-activated protein kinase 14 | / | 0.478 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.478 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.477 | |
| 2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.477 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.477 | |
| 2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.476 | |
| 3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.476 | |
| 1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.475 | |
| 2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.475 | |
| 4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.475 | |
| 3hdm | MMG | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.474 | |
| 3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.473 | |
| 4y3z | F41 | Endothiapepsin | 3.4.23.22 | 0.473 | |
| 1zem | NAD | Xylitol dehydrogenase | / | 0.472 | |
| 2gtn | LIE | Mitogen-activated protein kinase 14 | / | 0.472 | |
| 4is3 | NAD | 3alpha-hydroxy bile acid-CoA-ester 3-dehydrogenase 2 | 1.17.98.1 | 0.472 | |
| 3ndr | NAD | Pyridoxal 4-dehydrogenase | 1.1.1.107 | 0.471 | |
| 3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.471 | |
| 2c0o | L2G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.470 | |
| 4fuy | EK2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.470 | |
| 1gd1 | NAD | Glyceraldehyde-3-phosphate dehydrogenase | / | 0.469 | |
| 3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.469 | |
| 4c8b | 0LI | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.469 | |
| 4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.469 | |
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.468 | |
| 4aa0 | AA0 | Mitogen-activated protein kinase 14 | / | 0.468 | |
| 5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.468 | |
| 2o0u | C0M | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.467 | |
| 2r5t | ANP | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.467 | |
| 1mg5 | NAI | Alcohol dehydrogenase | 1.1.1.1 | 0.466 | |
| 1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.466 | |
| 2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.466 | |
| 2qd9 | LGF | Mitogen-activated protein kinase 14 | / | 0.466 | |
| 3c7q | XIN | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.466 | |
| 3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.466 | |
| 4bb4 | 32W | Ephrin type-B receptor 4 | 2.7.10.1 | 0.466 | |
| 4tuv | CPZ | Cytochrome P450 119 | 1.14 | 0.466 | |
| 3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.465 | |
| 3uvp | 048 | Mitogen-activated protein kinase 14 | / | 0.465 | |
| 1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.464 | |
| 3ac3 | KSH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.464 | |
| 3wmx | NAD | NAD dependent epimerase/dehydratase | / | 0.464 | |
| 4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.464 | |
| 1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.463 | |
| 2ath | 3EA | Peroxisome proliferator-activated receptor gamma | / | 0.463 | |
| 2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.463 | |
| 3i59 | N6R | CRP-like cAMP-activated global transcriptional regulator | / | 0.463 | |
| 4anx | 534 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.463 | |
| 1pnv | TYD | dTDP-epi-vancosaminyltransferase | 2.4.1.311 | 0.462 | |
| 1xdd | AAY | Integrin alpha-L | / | 0.462 | |
| 3nug | NAD | Pyridoxal 4-dehydrogenase | 1.1.1.107 | 0.462 | |
| 4fv0 | EK3 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.462 | |
| 2gs7 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.461 | |
| 3f5p | 741 | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.461 | |
| 4c7k | NAP | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.461 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.461 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.461 | |
| 3sp6 | IL2 | Peroxisome proliferator-activated receptor alpha | / | 0.460 | |
| 4a31 | 2CB | Glycylpeptide N-tetradecanoyltransferase | / | 0.460 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.460 | |
| 4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.460 | |
| 5jla | NAD | Putative short-chain dehydrogenase/reductase | / | 0.460 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.459 | |
| 1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.459 | |
| 2hfp | NSI | Peroxisome proliferator-activated receptor gamma | / | 0.459 | |
| 2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.459 | |
| 4fw8 | NAI | 3-oxoacyl-(Acyl-carrier-protein) reductase | / | 0.459 | |
| 4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.459 | |
| 2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.458 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.458 | |
| 3uzp | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.458 | |
| 3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.458 | |
| 3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.458 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.458 | |
| 5ez7 | FAD | Probable FAD-dependent oxidoreductase PA4991 | / | 0.458 | |
| 1rfv | ADP | Pyridoxal kinase | 2.7.1.35 | 0.457 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.457 | |
| 2ivv | PP1 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.457 | |
| 3e8n | VRA | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.457 | |
| 4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.457 | |
| 1iol | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.456 | |
| 1trb | FAD | Thioredoxin reductase | 1.8.1.9 | 0.456 | |
| 2e9u | A25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.456 | |
| 3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.456 | |
| 3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.456 | |
| 4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.456 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.456 | |
| 4l2i | FAD | Electron transfer flavoprotein alpha/beta-subunit | / | 0.456 | |
| 1cf3 | FAD | Glucose oxidase | 1.1.3.4 | 0.455 | |
| 1rrm | APR | Lactaldehyde reductase | 1.1.1.77 | 0.455 | |
| 1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.455 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.455 | |
| 2i5b | ADP | Pyridoxine kinase | / | 0.455 | |
| 3bv3 | P39 | Mitogen-activated protein kinase 14 | / | 0.455 | |
| 3nxx | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.455 | |
| 3r3s | NAD | Putative oxidoreductase | / | 0.455 | |
| 1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.454 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.454 | |
| 2zb1 | GK4 | Mitogen-activated protein kinase 14 | / | 0.454 | |
| 3clb | NAP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.454 | |
| 4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.454 | |
| 4fc0 | 0T2 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.454 | |
| 4h8a | NAI | Ureidoglycolate dehydrogenase (NAD(+)) | 1.1.1.350 | 0.454 | |
| 4kl9 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.454 | |
| 4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.454 | |
| 1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.453 | |
| 3cgb | FAD | Coenzyme A disulfide reductase | / | 0.453 | |
| 4ji9 | 1M3 | Tyrosine-protein kinase JAK2 | / | 0.453 | |
| 4kb8 | 1QO | Casein kinase I isoform delta | 2.7.11.1 | 0.453 | |
| 5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.453 | |
| 1c1d | NAI | Phenylalanine dehydrogenase | / | 0.452 | |
| 1di9 | MSQ | Mitogen-activated protein kinase 14 | / | 0.452 | |
| 1i7g | AZ2 | Peroxisome proliferator-activated receptor alpha | / | 0.452 | |
| 2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.452 | |
| 2itu | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.452 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.452 | |
| 2x8e | X8E | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
| 2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.452 | |
| 2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.452 | |
| 3dhe | AND | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.452 | |
| 3ksd | NAD | Glyceraldehyde-3-phosphate dehydrogenase 1 | / | 0.452 | |
| 4hjo | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.452 | |
| 4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.452 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.452 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.451 | |
| 2yxu | ATP | Pyridoxal kinase | 2.7.1.35 | 0.451 | |
| 3b8q | 900 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.451 | |
| 3d7z | GK5 | Mitogen-activated protein kinase 14 | / | 0.451 | |
| 3ggg | NAD | Prephenate dehydrogenase | / | 0.451 | |
| 3icr | FAD | Coenzyme A disulfide reductase | / | 0.451 | |
| 3nbw | TR4 | Ketohexokinase | / | 0.451 | |
| 4a87 | NAR | Major pollen allergen Bet v 1-A | / | 0.451 | |
| 4gt3 | ATP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.451 | |
| 4irn | FAD | AnaB | / | 0.451 | |
| 4q71 | FAD | Bifunctional protein PutA | / | 0.451 | |
| 1a7k | NAD | Glyceraldehyde-3-phosphate dehydrogenase, glycosomal | 1.2.1.12 | 0.450 | |
| 1ae1 | NAP | Tropinone reductase 1 | / | 0.450 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.450 | |
| 2brn | DF1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
| 2dte | NAI | Glucose 1-dehydrogenase related protein | / | 0.450 | |
| 2g82 | NAD | Glyceraldehyde-3-phosphate dehydrogenase | / | 0.450 | |
| 3mwu | BK3 | Calmodulin-domain protein kinase 1, putative | / | 0.450 | |
| 4bkj | STI | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.450 | |
| 4d9t | 0JG | Ribosomal protein S6 kinase alpha-3 | 2.7.11.1 | 0.450 | |
| 4ix6 | ADP | Uncharacterized protein | / | 0.450 | |
| 4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.450 | |
| 4jvf | 17X | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.450 | |
| 4loq | SB4 | Mitogen-activated protein kinase 14 | / | 0.450 | |
| 2oiq | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.449 | |
| 2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.449 | |
| 2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.449 | |
| 2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.449 | |
| 3ac5 | KZM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.449 | |
| 3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.449 | |
| 3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.449 | |
| 4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.449 | |
| 4g3j | VNT | Lanosterol 14-alpha-demethylase | / | 0.449 | |
| 4g7g | VFV | Lanosterol 14-alpha-demethylase | / | 0.449 | |
| 4h4u | NDP | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.449 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.449 | |
| 4mq2 | 2C4 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.449 | |
| 2rl5 | 2RL | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.448 | |
| 2vbd | V10 | Isopenicillin N synthase | 1.21.3.1 | 0.448 | |
| 2vxo | XMP | GMP synthase [glutamine-hydrolyzing] | 6.3.5.2 | 0.448 | |
| 2vyn | NAD | Glyceraldehyde-3-phosphate dehydrogenase A | / | 0.448 | |
| 3oez | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.448 | |
| 3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.448 | |
| 3zuy | TCH | Transporter | / | 0.448 | |
| 4eev | L1X | Hepatocyte growth factor receptor | 2.7.10.1 | 0.448 | |
| 4h1j | 0YH | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.448 | |
| 4ynt | FDA | Glucose oxidase, putative | / | 0.448 | |
| 1npt | NAD | Glyceraldehyde-3-phosphate dehydrogenase | / | 0.447 | |
| 2cdu | FAD | NADH oxidase | / | 0.447 | |
| 2hwr | DRD | Peroxisome proliferator-activated receptor gamma | / | 0.447 | |
| 2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.447 | |
| 2nr4 | FMN | Conserved protein | / | 0.447 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.447 | |
| 2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.447 | |
| 3cz7 | ACO | Histone acetyltransferase RTT109 | 2.3.1.48 | 0.447 | |
| 3mpa | SB2 | Mitogen-activated protein kinase 14 | / | 0.447 | |
| 3t14 | FAD | Sulfide-quinone reductase | / | 0.447 | |
| 1k6c | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
| 1k6t | XN1 | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
| 1qrp | HH0 | Pepsin A-4 | 3.4.23.1 | 0.446 | |
| 1tde | FAD | Thioredoxin reductase | 1.8.1.9 | 0.446 | |
| 1u3d | FAD | Cryptochrome-1 | / | 0.446 | |
| 1uu7 | BI2 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.446 | |
| 1ywn | LIF | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.446 | |
| 2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
| 2ooy | ATP | 5'-AMP-activated protein kinase subunit gamma | / | 0.446 | |
| 3lfe | Z84 | Mitogen-activated protein kinase 14 | / | 0.446 | |
| 4qi5 | FAD | Cellobiose dehydrogenase | / | 0.446 | |
| 4xq9 | NAD | Homospermidine synthase | 2.5.1.44 | 0.446 | |
| 4xwz | FAD | Fructosyl amine:oxygen oxidoreductase | / | 0.446 | |
| 1e6w | NAD | 3-hydroxyacyl-CoA dehydrogenase type-2 | 1.1.1.35 | 0.445 | |
| 1pn3 | TYD | dTDP-epi-vancosaminyltransferase | 2.4.1.311 | 0.445 | |
| 1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.445 | |
| 2bu9 | HFV | Isopenicillin N synthase | 1.21.3.1 | 0.445 | |
| 2c47 | 5ID | Casein kinase I isoform gamma-2 | / | 0.445 | |
| 2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.445 | |
| 2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.445 | |
| 3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.445 | |
| 3dl0 | AP5 | Adenylate kinase | / | 0.445 | |
| 3pvw | QRX | Beta-adrenergic receptor kinase 1 | 2.7.11.15 | 0.445 | |
| 3tti | KBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.445 | |
| 3ule | C69 | Actin-related protein 3 | / | 0.445 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.445 | |
| 4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.445 | |
| 4fv7 | E94 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.445 | |
| 4m6j | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
| 4mwh | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.445 | |
| 1fm6 | BRL | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
| 1rkx | NAD | CDP-D-glucose-4,6-dehydratase | / | 0.444 | |
| 2ekp | NAD | 2-deoxy-D-gluconate 3-dehydrogenase | / | 0.444 | |
| 2itv | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.444 | |
| 2itw | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.444 | |
| 3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.444 | |
| 3owj | 1EL | Casein kinase II subunit alpha | 2.7.11.1 | 0.444 | |
| 4h6r | FDA | Proline dehydrogenase | / | 0.444 | |
| 4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.444 | |
| 1hnc | GDN | Glutathione S-transferase Mu 2 | 2.5.1.18 | 0.443 | |
| 2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 3fhy | ATP | Pyridoxal kinase | 2.7.1.35 | 0.443 | |
| 3gqv | NAP | Enoyl reductase LovC | 1 | 0.443 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.443 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.443 | |
| 5dqr | FAD | 7-hydroxymethyl chlorophyll a reductase, chloroplastic | 1.17.7.2 | 0.443 | |
| 5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.443 | |
| 1g1a | NAD | dTDP-glucose 4,6-dehydratase | / | 0.442 | |
| 1ipe | NDP | Tropinone reductase 2 | 1.1.1.236 | 0.442 | |
| 2ch6 | ADP | N-acetyl-D-glucosamine kinase | 2.7.1.59 | 0.442 | |
| 2g5c | NAD | Prephenate dehydrogenase | / | 0.442 | |
| 2i4x | KGQ | Protease | / | 0.442 | |
| 2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.442 | |
| 3cps | NAD | Glyceraldehyde-3-phosphate dehydrogenase | / | 0.442 | |
| 3elu | SAM | Methyltransferase | / | 0.442 | |
| 3ggp | NAD | Prephenate dehydrogenase | / | 0.442 | |
| 3ioc | A5D | Pantothenate synthetase | 6.3.2.1 | 0.442 | |
| 3kf7 | L9G | Mitogen-activated protein kinase 14 | / | 0.442 | |
| 3qai | XNN | Ketohexokinase | / | 0.442 | |
| 3t1t | GDP | Probable gliding protein mglA | / | 0.442 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.442 | |
| 4i6a | HMG | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 1.1.1.88 | 0.442 | |
| 4iqg | NAP | Short-chain dehydrogenase/reductase SDR | / | 0.442 | |
| 5jsc | FAD | Putative acyl-CoA dehydrogenase | / | 0.442 | |
| 1e5q | NDP | Saccharopine dehydrogenase [NADP(+), L-glutamate-forming] | 1.5.1.10 | 0.441 | |
| 1e8x | ATP | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.441 | |
| 1psa | 0ZL | Pepsin A | 3.4.23.1 | 0.441 | |
| 2c54 | NAD | GDP-mannose 3,5-epimerase | 5.1.3.18 | 0.441 | |
| 2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.441 | |
| 2pl0 | STI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.441 | |
| 2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.441 | |
| 3e5r | NAD | Glyceraldehyde-3-phosphate dehydrogenase 1, cytosolic | 1.2.1.12 | 0.441 | |
| 3gob | HXX | DdmC | / | 0.441 | |
| 3hv5 | R24 | Mitogen-activated protein kinase 14 | / | 0.441 | |
| 3i0p | NAD | Malate dehydrogenase, putative | / | 0.441 | |
| 3qls | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
| 3vfq | AR6 | Poly [ADP-ribose] polymerase 14 | 2.4.2.30 | 0.441 | |
| 4nmj | NAP | Aldehyde dehydrogenase | / | 0.441 | |
| 4y8w | STR | Steroid 21-hydroxylase | / | 0.441 | |
| 5lc1 | NAD | L-threonine 3-dehydrogenase | / | 0.441 | |
| 1gte | FAD | Dihydropyrimidine dehydrogenase [NADP(+)] | 1.3.1.2 | 0.440 | |
| 1ml3 | NAD | Glyceraldehyde-3-phosphate dehydrogenase, glycosomal | 1.2.1.12 | 0.440 | |
| 1qvn | FRI | Interleukin-2 | / | 0.440 | |
| 1sny | NAP | LD36273p | / | 0.440 | |
| 1zrz | BI1 | Protein kinase C iota type | 2.7.11.13 | 0.440 | |
| 2p5u | NAD | UDP-glucose 4-epimerase | / | 0.440 | |
| 2xbm | SAH | Genome polyprotein | / | 0.440 | |
| 2xck | MH4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.440 | |
| 3bv2 | P38 | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 3dbv | NAD | Glyceraldehyde-3-phosphate dehydrogenase | / | 0.440 | |
| 3ggo | NAI | Prephenate dehydrogenase | / | 0.440 | |
| 3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.440 | |
| 3hja | NAD | Glyceraldehyde-3-phosphate dehydrogenase | / | 0.440 | |
| 3roc | 29A | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 3te5 | NAI | 5'-AMP-activated protein kinase subunit gamma | / | 0.440 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.440 | |
| 4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 4gj3 | 0XP | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.440 | |
| 4j54 | G52 | Gag-Pol polyprotein | 3.4.23.16 | 0.440 | |
| 4k9d | NAD | Glyceraldehyde-3-phosphate dehydrogenase | 1.2.1.12 | 0.440 |